| Name | Title | Contact Details |
|---|
Headquartered in Milford, Massachusetts, RenalGuard Solutions, Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard`s effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA. The RenalGuard System™ consists of a closed loop, software-controlled console and single-use sets that physicians and nurses use for automated matched fluid replacement to minimize over- or under-hydration of patients during medical procedures where creating and maintaining high urine outputs is beneficial.
EG GILERO is the merger of trusted companies in the medical device industry whose roots go back decades. GILERO Biomedical, Medacys, InField Medical and the medical businesses of eNNOVEA and ValTech Holdings have been brought together by EGI, Inc. to create one vertically integrated resource for the medical device industry. EG GILERO is your single-source, trusted partner for design, development and manufacturing within the medical devices, drug delivery, and primary pharmaceutical packaging markets. With operations in the United States and Asia, EG GILERO is strategically positioned to provide the value added services our clients require in a competitive, ever-changing global marketplace. Together, we will accelerate your device timelines from concept to commercialization.
Atm Laser Products & Services is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Bone Biologics was founded by University of California Los Angeles professors in collaboration with an Osaka University professor, and a USC surgeon in 2004. Formed to pursue regenerative medicine for bone, the company currently has as its strategic partners the Musculoskeletal Transplant Foundation, the nation's leading tissue bank and Orthofix, a leading global medical device company. Bone Biologics is currently focused on bone regeneration in spinal fusion using its recombinant human protein known as Nell-1. Nell-1 is an osteoinductive orthobiologic; a recombinant protein that provides control over bone regeneration. This patent protected technology has been exclusively licensed to Bone Biologics from UCLA.
Bios International Corp is a Butler, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.